Product: MORPHINE SULFATE 2MG/ML INJECTABLE	10 ML;  MORPHINE SULFATE MDV 10MG/ML INJECTABLE	10 ML  	25 ML  	30 ML;  MORPHINE SULFATE, P.F. (0.9%  SODIUM CHLORIDE) 50MG/ML INTRATHECAL	18 ML  	  	  	40 ML;  MORPHINE SULFATE, P.F. (0.9% SODIUM CHLORIDE) 15MG/ML INTRATHECAL	40 ML;  	  	  	  	  	  	  	  	  MORPHINE SULFATE, P.F. (0.9% SODIUM CHLORIDE) 20MG/ML INTRATHECAL	18 ML  	  	  	  	40 ML;  	  	  	  	  	  	  	  	  	  	  	  	  	  	  MORPHINE SULFATE, P.F. (0.9% SODIUM CHLORIDE) 25MG/ML INTRATHECAL	20 ML  
Reason for recall: Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.
Recall initiated: 20120521
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated